Texas Capital Bancshares, Inc. furnished a formal presentation deck titled 'Annual Governance Discussion Materials 2026' as part of its stockholder engagement program. The materials cover the company's governance structure, strategic plans, and financial condition for discussion with stockholders and other constituents.
Worthington Enterprises hosted an Investor and Analyst Day on November 10, 2026, to discuss its standalone strategy and performance since its separation from the steel processing business. The company introduced updated long-term financial targets and detailed growth opportunities across its Building Performance Solutions and Trade & Specialty Solutions segments.
Our Bond, Inc. founder and CEO Doron Kempel hosted a live webinar on November 13, 2026. The company furnished a formal presentation deck as an exhibit to the filing for the event.
Consumer Portfolio Services, Inc. (CPSS) released an updated 20-slide investor presentation providing a company overview as of September 30, 2026. The presentation highlights a $4.84 billion managed portfolio, 60 consecutive profitable quarters, and an expanded network of 13,000 approved dealers.
Star Equity Holdings, Inc. has furnished an updated investor presentation detailing its business operations as of September 30, 2026. The presentation highlights the company's strategy for creating shareholder value through organic growth, acquisitions, and share repurchases, and includes updates on its diversified holding company structure.
Revvity is hosting its 2026 Investor Day to showcase its 'Powering Scientific Intelligence' strategy, focusing on AI-enabled discovery workflows and its Life Sciences and Diagnostics portfolio. Management will outline strategic priorities, operational initiatives, and the company's long-range financial outlook to investors.
Aveanna Healthcare Holdings Inc. filed a formal investor presentation deck for November 2026. The presentation, filed under Item 7.01, provides a strategic and financial update to investors and is available on the company's investor relations website.
Praxis Precision Medicines hosted an Investor Day in New York City to detail its commercial strategy and launch plans for ulixacaltamide in essential tremor and relutrigine in DEEs. The company also provided an expanded pipeline update, including plans to initiate studies for ulixacaltamide in Parkinson’s disease and autism spectrum disorder in 2027.
Starling Oncology, Inc. furnished an updated investor presentation as Exhibit 99.1 to be used in upcoming meetings with investors. This filing is an amendment (Form 8-K/A) that supersedes a previous version of the presentation filed earlier the same day.
Senior management of USA Compression Partners, LP will attend a Texas Capital Securities investor event on November 17 and 18, 2026. The company will participate in meetings with the investment community and will post related presentation materials to its website prior to the event.
American Homes 4 Rent (AMH) has published a formal investor presentation titled 'Investor Highlights–November 2026' to its website and filed it with the SEC. The presentation provides strategic updates on the company's single-family rental portfolio, development program, and 2026 financial guidance. The filing is a standard Regulation FD disclosure intended to provide current highlights to analysts and investors.
FS KKR Capital Corp. announced that it will make investor presentations available on its website after the market close on November 12, 2026. The materials will be hosted on the company's investor relations page under the Events & Presentations section.
Weyerhaeuser Company filed a formal investor presentation outlining its strategic goals through 2030, including an accelerated growth strategy to add $1.5 billion of incremental Adjusted EBITDA. The presentation highlights long-term targets for its timberlands, wood products, and natural climate solutions businesses, as well as its capital allocation framework and sustainability goals.
Intellia Therapeutics hosted a webcast for investors and analysts titled 'Readying Lonvo-z for Patients with HAE' to discuss the development and commercialization strategy for its CRISPR-based therapy, lonvoguran ziclumeran. The presentation focused on the clinical data and market potential for lonvo-z in treating hereditary angioedema (HAE).
Expeditors International of Washington Investor Presentation
Expeditors International of Washington announced it will host its 2026 Investor Day in New York City on November 18, 2026. The event will feature presentations from the CEO, CFO, and other leadership members regarding company operations, strategic initiatives, and financial outlook. The company will also address investor questions during the session in lieu of its typical post-earnings Q&A filing.
TWFG, Inc. is hosting an Investor Day in The Woodlands, Texas, on November 12, 2026. The company filed its formal Investor Day Presentation as an exhibit, which includes strategic updates and forward-looking statements regarding its business operations and growth opportunities.
Interface, Inc. announced that it will present to investors at the Southwest IDEAS Investor Conference on November 19, 2026. The presentation will be webcast live at 9:15 a.m. Central Time and will be available for replay for at least 90 days.
QT Imaging Holdings, Inc. has published an updated investor presentation to its website and filed it with the SEC. The presentation provides supplemental product and operational information regarding the company's Breast Acoustic CT Scanner technology. The filing is intended to provide current and potential investors with strategic highlights and technical details of the company's imaging platform.
Civista Bancshares announced its participation in the Piper Sandler Financial Services Conference from November 16-18, 2026, in Miami, Florida. The company furnished its Third Quarter 2026 Investor Presentation, which outlines its strategic growth initiatives, credit quality, and financial performance metrics. Executive leadership will meet with institutional investors to discuss current banking trends and the company's long-term outlook.
Palomar Holdings, Inc. filed an updated corporate investor presentation to be used for meetings with analysts, stockholders, and at upcoming conferences. The presentation includes the company's strategic outlook and forward-looking financial targets for the remainder of 2026.
The Dixie Group, Inc. furnished an updated investor presentation for November 2026, superseding its previous presentation from August 2026. The materials provide a strategic overview of the company's history, its focus on the upper-end residential flooring market, and historical net sales data through 2025.
Patriot National Bancorp, Inc. posted an investor presentation to its website containing financial information for the third quarter of 2026. The presentation was formally furnished as Exhibit 99.1 to the 8-K filing under Regulation FD.
Starling Oncology, Inc. has prepared a formal investor presentation to be used in upcoming meetings with investors. The presentation, dated November 12, 2026, was furnished as an exhibit to the 8-K filing and includes a discussion of the company's strategy and financial trends.
Datacentrex, Inc. has prepared and furnished a formal investor presentation deck (Exhibit 99.1) regarding its operations and performance. Management intends to use these materials for upcoming presentations to investors and analysts.
ProMIS Neurosciences Inc. has posted an updated corporate presentation to its website and filed it as an exhibit to its 8-K. The presentation provides a strategic overview of the company's development pipeline, including its PMN310 candidate for Alzheimer's disease and the PRECISE-AD Phase 1b clinical trial. The filing serves as a Regulation FD disclosure to provide investors with current information on the company's operations and clinical milestones.
Apollo Global Management's subsidiary, Athene Holding Ltd., is hosting a Fixed Income Investor call on November 12, 2026. The company has made a formal investor presentation available on its website to provide updates on business trends, new business origination, and its investment portfolio.
First Watch Restaurant Group Investor Presentation
First Watch Restaurant Group is hosting its inaugural Investor Day in Boston to share its strategic growth vision and long-term financial targets through 2028. The company outlined a path to over 2,200 restaurants and expects to generate positive free cash flow beginning in 2027 to self-fund organic growth.
“Our strategy combines the strength of our leadership in Daytime Dining with substantial whitespace for restaurant growth and an increasingly powerful cash flow model. We see a clear path to more than 2,200 restaurants across the continental U.S. while, beginning next year, we expect our robust cash flow to self-fund organic growth and maintenance capital expenditures and accelerate free cash flow generation.”
Chris Tomasso, CEO and President of First Watch
“Our annual growth targets through 2028 strike an optimized balance between new unit growth and free cash flow. We are on track to open 62 systemwide restaurants in 2026 and approximately 55 in 2027, retaining flexibility on annual openings in the following years.”
Athene Holding Ltd. has made available a formal presentation titled 'Athene Fixed Income Investor Presentation November 2026' in connection with a fixed income investor call. The presentation was published on the company's investor relations website on November 12, 2026.
Kraft Heinz is hosting its 2026 Investor Day to outline a strategic path for sustainable, volume-led profitable growth through 2029. The company expects to return to top- and bottom-line growth in the second half of 2027 and aims for double-digit total shareholder return by 2029 through a self-reinforcing cycle of growth and capital returns.
Arbutus Biopharma Corporation has posted an updated corporate presentation for Q4 2026 to its website and filed it with the SEC. The presentation outlines the company's strategic focus on developing a functional cure for chronic hepatitis B virus (HBV), including the clinical development of its lead candidate imdusiran. The filing serves as a routine update for investors regarding the company's pipeline, clinical trial designs, and future prospects.